FORM 8-K

Company

Eton Pharmaceuticals, Inc.

Filed

January 3, 2025

Period of Report

December 31, 2024

Accession Number

0001437749-25-000109

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →